Stoneridge Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$4.46M |
| 2 |
Dollar Tree
DLTR
|
+$4.16M |
| 3 |
Kimberly-Clark
KMB
|
+$3.37M |
| 4 |
Pfizer
PFE
|
+$3.19M |
| 5 |
Citigroup
C
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$6.83M |
| 2 |
Dollar General
DG
|
+$2.88M |
| 3 |
Medtronic
MDT
|
+$2.78M |
| 4 |
Republic Services
RSG
|
+$2.54M |
| 5 |
General Motors
GM
|
+$2.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.18% |
| 2 | Financials | 12.89% |
| 3 | Healthcare | 12% |
| 4 | Communication Services | 9.39% |
| 5 | Consumer Discretionary | 8.25% |
Similar funds
Stoneridge Investment Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Stoneridge Investment Partners held 121 positions worth $212M, down 7.9% from $230M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Stoneridge Investment Partners withdrew a net $7.36M in Q3 2023, closing 21 positions and reducing 64 holdings. Its most notable exit was Medtronic, an estimated $2.78M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Stoneridge Investment Partners opened a new position in Dollar Tree worth $3.31M.
- Stoneridge Investment Partners's largest Q3 2023 buy was Dollar Tree: 31,081 shares worth $3.31M.
- Stoneridge Investment Partners added most to Zimmer Biomet in Q3 2023, an estimated $4.46M increase.
- Stoneridge Investment Partners's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $6.83M.
- Stoneridge Investment Partners fully exited Medtronic in Q3 2023, selling an estimated $2.78M.
- Stoneridge Investment Partners's ten largest holdings make up 35% of its $212M portfolio in Q3 2023.
- Stoneridge Investment Partners opened 14 new positions and closed 21 in Q3 2023.
- Stoneridge Investment Partners's portfolio value fell 7.9% quarter-over-quarter to $212M.
Based on Stoneridge Investment Partners's 13F filing for Q3 2023, filed 3 Nov 2023.